Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...
AP reveals new developments in autoimmune disease medicine through extraordinary patient experiences
Told through people who have had their memories, sanity and childhoods stolen by autoimmune disease, the AP reveals and explains exciting new developments ...
10hon MSN
Inflammation and metabolic stress combine to drive a new cell death pathway—mitoxyperilysis
In several disease conditions, including infections and cancers, innate immune activation and nutrient scarcity occur ...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive degradation of brain cells, as well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback